- Biopharma
- Nonclinical
- Therapeutic areas
- Preclinical oncology
- Cell lines
- CT26 WT-luc-mCh-Puro: Mouse Colon Carcinoma
![CT26 WT-luc-mCh-Puro: Mouse Colon Carcinoma](/content/dam/labcorp/images/charts-and-graphs/cell-lines/ct26-wt-luc-mch-puro.png)
Parameter | Information |
---|---|
Strain | Balb/c |
Implant Type | Fragment |
Implant Location | OT - colon |
Time to Staging | 3 days |
Time to 750mm3 | N/A |
Td | 1.5 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Spotlight on CT26 WT-luc-mCh-Puro: Mouse Colon Carcinoma
Learn more about this cell line in our scientific spotlights:
The advent of therapies harnessing the intrinsic anti-tumor activity of the immune system against cancer represents a paradigm shift in oncology therapeutics that has permanently changed the future of how we fight cancer.